Linked Life Data

11172968

Source:http://linkedlifedata.com/resource/pubmed/id/11172968

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-2-22
pubmed:abstractText
Interstitial brachytherapy treatment plans are conventionally optimized with respect to total target dose and dose homogeneity, which does not account for the biologic effects of dose rate. In an HDR implant, with a stepping source, the dose rate dramatically changes during the course of treatment, depending on location, as the source moves from dwell position to dwell position. These widely varying dose rates, together with the related sequencing of the dwell positions, may impart different biologic effects at points receiving the same total dose. This study applies radiobiologic principles to account for the potential biologic impact of dose delivery at varying dose rates within an HDR implant.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0360-3016
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
839-45
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
Biologic treatment planning for high-dose-rate brachytherapy.
pubmed:affiliation
Department of Radiation Oncology, Medical College of Virginia Hospitals of Virginia Commonwealth University (VCU), P.O. Box 980058, Richmond, VA 23298-0058, USA.
pubmed:publicationType
Journal Article